Elizabeth Talbot, MD
Infectious Disease · Lebanon, NHNPI 1366465189
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $45,300 of the $55,841 with a category attached, or 81.1%. Oxford Immunotec USA Inc accounts for 60.7% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $39,801 and has fallen 80.0% since, to $7,965 in 2025. Among infectious disease clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $1551.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Oxford Immunotec USA Inc$34K
- Insmed, Inc.$14K
- Mannkind Corporation$5K
- Revvity, Inc.$3K
Across 30 payments — averaging $8575.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$143K
- Paratek Pharmaceuticals, Inc.$112K
- Mannkind Corporation$2K
What the payments were for
- Consulting fees$45,30081%
- Speaking & faculty fees$7,50013%
- Travel & lodging$2,2104%
- Food & beverage$7321%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Oxford Immunotec USA Inc | 11 | $33,908 |
| Insmed, Inc. | 21 | $13,968 |
| Mannkind Corporation | 3 | $4,965 |
| Revvity, Inc. | 1 | $3,000 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TSPOT TB TEST$33,563
- Arikayce$10,644
- T-SPOT.TB50$3,000
- T-SPOT.TB8$260
How this compares
$55,841 in reported general payments places this provider in the 95th percentile of 33 infectious disease providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ArikayceAmikacin Liposomal/Neb.Accessr | 20 | $312,295 |
| SirturoBedaquiline Fumarate | 13 | $49,656 |
| Rifabutin | 27 | $15,447 |
| Daptomycin | 25 | $5,877 |
| Azithromycin | 171 | $4,324 |
| Ethambutol Hcl | 92 | $3,936 |
| Ampicillin-SulbactamAmpicillin Sod/Sulbactam Sod | 17 | $3,307 |
| Atovaquone-Proguanil HclAtovaquone/Proguanil Hcl | 41 | $3,028 |
| Rifampin | 50 | $2,931 |
| Voriconazole | 11 | $1,333 |
| CeftriaxoneCeftriaxone Sodium | 43 | $1,139 |
| Ampicillin Sodium | 11 | $751 |
| Cephalexin | 13 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Insmed, Inc.Arikayce | $13,968 | $312,29520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 33 infectious disease providers in New Hampshire.
Other infectious disease in Lebanon
- Antonia AltomareLebanon$1K
- Gabriela Andujar VazquezLebanon$514
- Anais OvalleLebanon$136
- Harmony TynerLebanon$81
- David de GijselLebanon$21
- Rebecca WangLebanon$20
- Patrick PassarelliLebanon$16
- Bryan MarshLebanon$0
- Ruth BerggrenLebanon$0
- Richard ZuckermanLebanon$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.